Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: Regulation and functional implications

American Journal of Pathology

Volumn 170, Issue 1, 2007, Pages 126-139

  Gellersen, Birgit ^a   Briese, Juliane ^b   Oberndörfer, Marine ^b   Redlin, Katja ^a   Samalecos, Annemarie ^a   Richter, Dagmar Ulrike ^c   Löning, Thomas ^b   Schulte, Heinrich Maria ^a   Bamberger, Ana Maria ^b  

^a ENDOKRINOLOGIKUM HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD82 ANTIGEN; CYCLIC AMP; DECORIN; INTERLEUKIN 1BETA; PROGESTERONE; KAI1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; DECIDUA; ENDOMETRIUM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MOTHER FETUS RELATIONSHIP; PRIORITY JOURNAL; RNA INTERFERENCE; TROPHOBLAST; WESTERN BLOTTING; CELL COMMUNICATION; CELL CULTURE; CELL MOTION; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; PREGNANCY;

CELL COMMUNICATION; CELL MOVEMENT; CELLS, CULTURED; DECIDUA; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; KANGAI-1 PROTEIN; PREGNANCY; TROPHOBLASTS; TUMOR SUPPRESSOR PROTEINS;

EID: 33847082206     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060175     Document Type: Article

References (62)

1. Gellersen B, Brosens JJ: Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair. J Endocrinol 2003, 178:357-372
2. Dimitriadis E, White CA, Jones RL, Salamonsen LA: Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update 2005, 11:613-630
3. Frank GR, Brar AK, Jikihara H, Cedars MI, Handwerger S: Interleukin-18 and the endometrium: an inhibitor of stromal cell differentiation and possible autoregulator of decidualization in humans. Biol Reprod 1995, 52:184-191
4. Dosiou C, Giudice LC: Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev 2005, 26:44-62
5. King A: Uterine leukocytes and decidualization. Hum Reprod Update 2000, 6:28-36
6. Kliman HJ: Uteroplacental blood flow: the story of decidualization, menstruation, and trophoblast invasion. Am J Pathol 2000, 157:1759-1768
7. Fazleabas AT, Kim JJ, Strakova Z: Implantation: embryonic signals and the modulation of the uterine environment: a review. Placenta 2004, 25(Suppl A):S26-S31
8. Red-Horse K, Zhou Y, Genbacev O, Prakobhol A, Foulk R, McMaster M, Fisher SJ: Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 2004, 114:744-754
9. Shih IM, Kurman RJ: Molecular basis of gestational trophoblastic diseases. Curr Mol Med 2002, 2:1-12
10. Brosens JJ, Pijnenborg R, Brosens IA: The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 2002, 187:1416-1423
11. Cohen M, Meisser A, Bischof P: Metalloproteinases and human placental invasiveness. Placenta 2006, 27:783-793
12. Burrows TD, King A, Loke YW: Trophoblast migration during human placental implantation. Hum Reprod Update 1996, 2:307-321
13. Salamonsen LA: Role of proteases in implantation. Rev Reprod 1999, 4:11-22
14. Frank HG, Kaufmann P: Nonvillous parts and trophoblast invasion. Pathology of the Human Placenta. Edited by K Bernischke, P Kaufmann. New York, Springer Verlag, 2000, pp 171-272
15. Minas V, Loutradis D, Makrigiannakis A: Factors controlling blastocyst implantation. Reprod Biomed Online 2005, 10:205-216
16. Xu G, Guimond MJ, Chakraborty C, Lala PK: Control of proliferation, migration, and invasiveness of human extravillous trophoblast by decorin, a decidual product. Biol Reprod 2002, 67:681-689
17. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995, 268:884-886
18. Kauffman EC, Robinson VL, Stadler WM, Sokoloff MH, Rinker-Schaeffer CW: Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol 2003, 169:1122-1133
19. Hemler ME: Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 2003, 19:397-422
20. Lagaudrière-Gesbert C, Lebel-Binay S, Hubeau C, Fradelizi C, Conjeaud H: Signaling through the tetraspanin CD82 triggers its association with the cytoskeleton leading to sustained morphological changes and T cell activation. Eur J Immunol 1998, 28:4332-4344
21. Shibagaki N, Hanada K, Yamashita H, Shimada S, Hamada H: Overexpression of CD82 on human T cells enhances LFA-1/ICAM-1-mediated cell-cell adhesion: functional association between CD82 and LFA-1 in T cell activation. Eur J Immunol 1999, 29:4081-4091
22. Odintsova E, Sugiura T, Berditchevski F: Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr Biol 2000, 10:1009-1012
23. Odintsova E, Voortman J, Gilbert E, Berditchevski F: Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR. J Cell Sci 2003, 116:4557-4566
24. Jackson P, Marreiros A, Russell PJ: Kai1 tetraspanin and metastasis suppressor. Int J Biochem Cell Biol 2005, 37:530-534
25. Jee BK, Park KM, Surendran S, Lee WK, Han CW, Kim YS, Lim Y: KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line. Biochem Biophys Res Commun 2006, 342:655-661
26. Sridhar SC, Miranti CK: Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases. Oncogene 2006, 25:2367-2378
27. Bandyopadhyay S, Zhan R, Chaudhuri A, Watabe M, Pai SK, Hirota S, Hosobe S, Tsukada T, Miura K, Takano Y, Saito K, Pauza ME, Hayashi S, Wang Y, Mohinta S, Mashimo T, Iiizumi M, Furuta E, Watabe K: Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med 2006, 12:933-938
28. Rinker-Schaeffer CW, Hickson JA: Stopping cancer before it colonizes. Nat Med 2006, 12:887-888
29. Gellersen B, Kempf R, Telgmann R, DiMattia GE: Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 1994, 8:356-373
30. Gellersen B, Kempf R, Telgmann R: Human endometrial stromal cells express novel isoforms of the transcriptional modulator CREM and up-regulate ICER in the course of decidualization. Mol Endocrinol 1997, 11:97-113
31. Kam EPY, Gardner L, Loke YW, King A: The role of trophoblast in the physiological change in decidual spiral arteries. Hum Reprod 1999, 14:2131-2138
32. Lebel-Binay S, Gil ML, Lagaudriere C, Miloux B, Marchiol-Fournigault C, Quillet-Mary A, Lopez M, Fradelizi D, Conjeaud H: Further characterization of CD82/IA4 antigen (type III surface protein): an activation/differentiation marker of mononuclear cells. Cell Immunol 1994, 154:468-483
33. Telgmann R, Maronde E, Tasken K, Gellersen B: Activated protein kinase A is required for differentiation-dependent transcription of the decidual prolactin gene in human endometrial stromal cells. Endocrinology 1997, 138:929-937
34. Wu Q, Ji Y, Zhang MQ, Chen YQ, Chen F, Shi DL, Zheng ZH, Huang YJ, Su WJ: Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells. Cell Tissue Res 2003, 314:237-249
35. Pohnke Y, Schneider-Merck T, Fahnenstich J, Kempf R, Christian M, Milde-Langosch K, Brosens JJ, Gellersen B: Wild-type p53 protein is up-regulated upon cyclic AMP-induced differentiation of human endometrial stromal cells. J Clin Endocrinol Metab 2004, 89:5233-5244
36. Cannon KS, Cresswell P: Quality control of transmembrane domain assembly in the tetraspanin CD82. EMBO J 2001, 20:2443-2453
37. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, Rosenfeld MG: Exchange of N-CoR corepressor and Tip60 coaotivator complexes links gene expression by NF-κB and β-amyloid precursor protein. Cell 2002, 110:55-67
38. Strakova Z, Srisuparp S, Fazleabas AT: Interleukin-1β induces the expression of insulin-like growth factor binding protein-1 during decidualization in the primate. Endocrinology 2000, 141:4664-4670
39. Brar A, Handwerger S, Kessler CA, Aronow BJ: Gene induction and categorical reprogramming during in vitro human endometrial fibroblast decidualization. Physiol Genomics 2001, 7:135-148
40. Seo NS, Hocking AM, Höök M, McQuillan DJ: Decorin core protein secretion is regulated by N-linked oligosaccharide and glycosaminoglycan additions. J Biol Chem 2005, 280:42774-42784
41. Makrigiannakis A, Minas V, Kalantaridou SN, Nikas G, Chrousos GP: Hormonal and cytokine regulation of early implantation. Trends Endocrinol Metab 2006, 17:178-185
42. Bamberger AM, Minas V, Kalantaridou SN, Radde J, Sadeghian H, Loning T, Charalampopoulos I, Brummer J, Wagener C, Bamberger CM, Schulte HM, Chrousos GP, Makrigiannakis A: Corticotropin-releasing hormone modulates human trophoblast invasion through carcinoembryonic antigen-related cell adhesion molecule-1 regulation. Am J Pathol 2006, 168:141-150
43. Telgmann R, Gellersen B: Marker genes of decidualization: activation of the decidual prolactin gene. Hum Reprod Update 1998, 4:472-479
44. Gilchrist RL, Ryu K-S, Ji I, Ji TH: The luteinizing hormone/chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals. J Biol Chem 1996, 271:19283-19287
45. Brosens JJ, Hayashi N, White JO: Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells. Endocrinology 1999, 140:4809-4820
46. Mashimo T, Watabe M, Hirota S, Hosobe S, Miura K, Tegtmeyer PJ, Rinker-Shaeffer CW, Watabe K: The expression of KAI1 gene, a tumor metastatis suppressor, is directly activated by p53. Proc Natl Acad Sci USA 1998, 95:11307-11311
47. Marreiros A, Dudgeon K, Dao V, Grimm MO, Czolij R, Crossley M, Jackson P: KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells. Oncogene 2005, 24:637-649
48. Duriez C, Falette N, Cortes U, Moyret-Lalle C, Puisieux A: Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage. Oncogene 2000, 19:2461-2464
49. Marreiros A, Czolij R, Yardley G, Crossley M, Jackson P: Identification of regulatory regions within the Kai1 promoter: a role for binding of AP1, AP2 and p53. Gene 2003, 302:155-164
50. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, Chen H, Jenner R, Herbolsheimer E, Jacobsen E, Kadam S, Ecker JR, Emerson B, Hogenesch JB, Unterman T, Young RA, Montminy M: Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 2005, 102:4459-4464
51. Li J, Peet GW, Balzarano D, Li X, Massa P, Barton RW, Marcu KB: Novel NEMO/IκB kinase and NF-κB target genes at the pre-B to immature B cell transition. J Biol Chem 2001, 276:18579-18590
52. Kim JH, Kim B, Cai L, Choi HJ, Ohgi KA, Tran C, Chen C, Chung CH, Huber O, Rose DW, Sawyers CL, Rosenfeld MG, Baek SH: Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes. Nature 2005, 434:921-926
53. Floridon C, Nielsen O, Hølund B, Sunde L, Westergaard JG, Thomsen SG, Teisner B: Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies. Placenta 1999, 20:711-721
54. Bass R, Werner F, Odintsova E, Sugiura T, Berditchevski F, Ellis V: Regulation of urokinase receptor proteolytic function by the tetraspanin CD82. J Biol Chem 2005, 280:14811-14818
55. Cook GA, Longhurst CM, Grgurevich S, Cholera S, Crossno JT Jr, Jennings LK: Identification of CD9 extracellular domains important in regulation of CHO cell adhesion to fibronectin and fibronectin pericellular matrix assembly. Blood 2002, 100:4502-4511
56. 2 and TGF-β1. J Leukocyte Biol 2005, 77:948-957
57. Delaguillaumie A, Lagaudriere-Gesbert C, Popoff MR, Conjeaud H: Rho GTPases link cytoskeletal rearrangements and activation processes induced via the tetraspanin Cd82 in T lymphocytes. J Cell Sci 2002, 115:433-443
58. Reed CC, Waterhouse A, Kirby S, Kay P, Owens RT, McQuillan DJ, Iozzo RV: Decorin prevents metastatic spreading of breast cancer. Oncogene 2005, 24:1104-1110
59. Seidler DG, Goldoni S, Agnew C, Cardi C, Thakur ML, Owens RT, McQuillan DJ, Iozzo RV: Decorin protein core inhibits in vivo cancer growth and metabolism by hindering EGF receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem 2006, 281:26408-26418
60. Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC, Iozzo RV: Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem 2005, 280:32468-32479
61. Leach RE, Kilburn B, Wang J, Liu Z, Romero R, Armant DR: Heparin-binding EGF-like growth factor regulates human extravillous cytotrophoblast development during conversion to the invasive phenotype. Dev Biol 2004, 266:223-237
62. Szabo A, Perou CM, Karaca M, Perreard L, Quackenbush JF, Bernard PS: Statistical modeling for selecting housekeeper genes. Genome Biol 2004, 5:R59